BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7636562)

  • 1. Three-drug combination of cisplatin, dacarbazine, and tamoxifen in metastatic malignant melanoma.
    Chmielowska E; Potemski P; PluzaƄska A
    J Clin Oncol; 1995 Aug; 13(8):2146-7. PubMed ID: 7636562
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract]   [Full Text] [Related]  

  • 3. The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).
    Flaherty LE; Liu PY; Mitchell MS; Fletcher WS; Walker MJ; Goodwin JW; Stephens RL; Sondak VK
    Am J Clin Oncol; 1996 Apr; 19(2):108-13. PubMed ID: 8610631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
    Buzaid AC; Murren JR; Durivage HJ
    Cancer; 1991 Sep; 68(6):1238-41. PubMed ID: 1873775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
    Rosenberg SA; Yang JC; Schwartzentruber DJ; Hwu P; Marincola FM; Topalian SL; Seipp CA; Einhorn JH; White DE; Steinberg SM
    J Clin Oncol; 1999 Mar; 17(3):968-75. PubMed ID: 10071291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.
    Stein ME; Bernstein Z; Drumea K; Zalik M; Shklar Z; Steiner M; Haim N
    Am J Clin Oncol; 1999 Feb; 22(1):62-4. PubMed ID: 10025383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy of metastatic melanoma.
    Berd D; Mastrangelo MJ
    J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
    Rusthoven JJ; Quirt IC; Iscoe NA; McCulloch PB; James KW; Lohmann RC; Jensen J; Burdette-Radoux S; Bodurtha AJ; Silver HK; Verma S; Armitage GR; Zee B; Bennett K
    J Clin Oncol; 1996 Jul; 14(7):2083-90. PubMed ID: 8683240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
    Cocconi G
    Cancer; 1992 Aug; 70(4):902. PubMed ID: 1643625
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of malignant melanoma].
    Jedrzejczak WW
    Pol Arch Med Wewn; 1998 Oct; 100(4):294-9. PubMed ID: 10335037
    [No Abstract]   [Full Text] [Related]  

  • 13. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up.
    Lattanzi SC; Tosteson T; Chertoff J; Maurer LH; O'Donnell J; LeMarbre PJ; Mott L; DelPrete SA; Forcier RJ; Ernstoff MS
    Melanoma Res; 1995 Oct; 5(5):365-9. PubMed ID: 8541728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma.
    Luger SM; Kirkwood JM; Ernstoff MS; Vlock DR
    J Natl Cancer Inst; 1990 Dec; 82(24):1934-7. PubMed ID: 2250315
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
    Cocconi G; Bella M; Calabresi F; Tonato M; Canaletti R; Boni C; Buzzi F; Ceci G; Corgna E; Costa P
    N Engl J Med; 1992 Aug; 327(8):516-23. PubMed ID: 1635566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
    McClay EF; Mastrangelo MJ; Bellet RE; Berd D
    Cancer Treat Rep; 1987 May; 71(5):465-9. PubMed ID: 3567970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
    Crowell EB; Higa GM
    W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.
    Wojtukiewicz MZ; Kozlowski L; Ostrowska K; Dmitruk A; Zacharski LR
    Thromb Haemost; 2003 Feb; 89(2):405-7. PubMed ID: 12574822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.